Therma Bright Inc V.THRM

Alternate Symbol(s): TBRIF

Healthcare Medical Devices

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.

TSXV:THRM - Post by User

Therma Bright Inc

<< Previous

Bullboard Posts

Next >>

Post by Vincenzovegaon Jan 12, 2022 10:30am

202 Views

Post# 34307855

Puzzle coming together

With what Kushman been saying along with others, they seen to be isolating the person who work on the trail for therma, where the doctor quoted "So proud that I was able to help with this trial... very exciting!
So as Kushman says - it sounds like the test may have been completed and there may be some truth to the rumor that all we are waiting for is the PCR tests validating AcuVid test results and the compilation of the of these results before final submission to US FDA for approval

The timelines supports this:
Study Status


Record Verification:	November 2021 December 2021
Overall Status:	Not yet recruiting Recruiting
Study Start:	November 2021 December 6, 2021
Primary Completion:	December 31, 2021 [Anticipated]
Study Completion:	December 2021 January 2022 [Anticipated]

First Submitted:	November 11, 2021
First Submitted that Met QC Criteria:	November 11, 2021
First Posted:	November 15, 2021 [Actual]

Last Update Submitted that Met QC Criteria:	November 11, 2021 December 21, 2021
Last Update Posted:	November 15, 2021 [Actual] January 11, 2022 [Actual]